TRIPLE NEGATIVE BREAST NEOPLASMS
Clinical trials for TRIPLE NEGATIVE BREAST NEOPLASMS explained in plain language.
Never miss a new study
Get alerted when new TRIPLE NEGATIVE BREAST NEOPLASMS trials appear
Sign up with your email to follow new studies for TRIPLE NEGATIVE BREAST NEOPLASMS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New combo therapy aims to extend life in tough breast cancer
Disease control OngoingThis study tests whether adding capivasertib to standard chemotherapy (paclitaxel) helps people with advanced triple-negative breast cancer live longer. About 923 participants receive either the combination or a placebo plus chemotherapy. The goal is to see if the new drug improv…
Matched conditions: TRIPLE NEGATIVE BREAST NEOPLASMS
Phase: PHASE3 • Sponsor: AstraZeneca • Aim: Disease control
Last updated May 26, 2026 03:18 UTC
-
New drug cocktail aims to tame aggressive breast cancer
Disease control OngoingThis study tests whether combining the immunotherapy drug durvalumab with other cancer treatments (with or without chemotherapy) can help control metastatic triple-negative breast cancer in people who haven't had prior treatment for advanced disease. About 243 women with advanced…
Matched conditions: TRIPLE NEGATIVE BREAST NEOPLASMS
Phase: PHASE1, PHASE2 • Sponsor: AstraZeneca • Aim: Disease control
Last updated May 26, 2026 03:17 UTC
-
New drug combo targets Hard-to-Treat cancers in early trial
Disease control OngoingThis early-phase study tests a new drug called KFA115, alone or with pembrolizumab, in people with advanced cancers like lung, melanoma, and kidney cancer. The main goal is to find a safe dose and understand side effects. About 126 participants will take part to see if the treatm…
Matched conditions: TRIPLE NEGATIVE BREAST NEOPLASMS
Phase: PHASE1 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated May 26, 2026 03:17 UTC
-
New drug BT8009 shows promise in battling Hard-to-Treat cancers
Disease control OngoingThis study tests a new drug called BT8009, given alone or with another drug (pembrolizumab), in people with advanced solid tumors like bladder, breast, lung, or ovarian cancer that have not responded to standard treatments. The goal is to see if the drug is safe and can shrink tu…
Matched conditions: TRIPLE NEGATIVE BREAST NEOPLASMS
Phase: PHASE1, PHASE2 • Sponsor: BicycleTx Limited • Aim: Disease control
Last updated May 26, 2026 03:03 UTC
-
New chemo combo aims to wipe out aggressive breast cancer before surgery
Disease control OngoingThis study tests whether adding the drug capecitabine to standard chemotherapy before surgery can completely eliminate early triple-negative breast cancer. About 325 adults with node-positive or larger tumors are participating. The main goal is to see if the combination leads to …
Matched conditions: TRIPLE NEGATIVE BREAST NEOPLASMS
Phase: PHASE3 • Sponsor: Lund University Hospital • Aim: Disease control
Last updated May 11, 2026 20:50 UTC